Incidentaloma Frameworks
- An incidentaloma is a lesion you weren't looking for, found while looking for something else — most are harmless, but "most" isn't "all."
- The job isn't to diagnose every one on the spot; it's to sort each into ignore it, watch it, or work it up using a published framework.
- Each organ has its own rulebook (Fleischner for lung nodules, Bosniak for renal cysts, washout for adrenals, and so on) — they all balance the same two fears: missing a cancer vs. terrifying a healthy person.
- The decision hinges on a handful of features: size, growth, fat, enhancement, and the patient's cancer risk. Memorize the axes, look up the exact cutoffs.
- Following the framework protects the patient (and you) far better than a gut feeling ever will.
You ordered a CT to chase a kidney stone, and the scanner — being a thorough, slightly nosy houseguest — also photographed the patient's adrenal glands, liver, lungs, and pancreas on the way through. Somewhere in all that free real estate, it found a spot. Congratulations: you have an incidentaloma. Now what?
This is one of the most common situations in all of imaging, and it's quietly stressful, because the spot doesn't come with a label. Most incidentalomas are nothing — benign clutter the body accumulates like junk in a garage. But a few are early cancers caught by pure luck. The whole game is telling those two groups apart without putting every patient through a biopsy.
The core tension: two ways to be wrong
Imagine a smoke detector. Set it too sensitive and it shrieks every time you make toast; set it too dull and your kitchen burns down. Incidentaloma management is exactly this dial, and the two failure modes are:
- Under-call it — you wave off a small cancer, and it shows up two years later much bigger.
- Over-call it — you send a healthy person down a rabbit hole of scans, needles, anxiety, and the occasional complication, all to confirm a harmless lump.
Neither is free. So instead of trusting any individual radiologist's mood that afternoon, the field built frameworks: published, evidence-based recipes that tell you what to do with a given finding. They're the smoke detector's calibration, agreed on by committee so you don't have to redesign it at 2 a.m.
A framework's real gift isn't the answer — it's defensible consistency. Two radiologists, two cities, same nodule, same recommendation. That reproducibility is what makes follow-up actually work.
The features every framework leans on
Here's the reassuring part: the organ-specific rulebooks look intimidating, but they're all stirring the same small pot of ingredients. Learn the ingredients and the recipes stop being scary.
| Feature | What it tells you | Plain-English version |
|---|---|---|
| Size | Bigger lesions are likelier to matter | A pea is boring; a golf ball gets attention. |
| Growth over time | Change is the loudest alarm | A spot that grows on serial scans has lost the benefit of the doubt. |
| Fat content | Macroscopic fat usually means benign | Fat inside a lesion is a friendly handshake (think adrenal myelolipoma, renal angiomyolipoma). |
| Enhancement | Living, vascular tissue lights up with contrast | Tumors recruit blood supply; simple fluid doesn't. |
| Patient risk | Same spot, different stakes | A nodule in a lifelong smoker is not the same nodule in a 30-year-old. |
Notice that last row. The finding never changes meaning in a vacuum — the pre-test probability does. A 6 mm lung nodule in a 30-year-old with no risk factors and the same 6 mm nodule in a lifelong smoker with a prior cancer are two completely different conversations.
A tour of the big rulebooks
You don't apply one universal framework; you reach for the one that matches the organ. A quick map of the heavy hitters:
- Lung nodules → the Fleischner Society guidelines. For incidental solitary pulmonary nodules on CT, Fleischner sorts by size, solid vs. subsolid character, and risk to tell you whether to ignore it, rescan later, or push further. (Note: Fleischner is for incidental nodules, not for lung-cancer screening — that's Lung-RADS, a different lane.)
- Renal masses → the Bosniak classification. Cystic renal masses get a Bosniak category based on walls, septa, calcification, and — the big one — enhancement, climbing from "simple cyst, forget it" up to "this needs surgery."
- Adrenal nodules → the washout / density approach. An adrenal lesion that's low in density on non-contrast CT — meaning it's rich in microscopic intracellular lipid, not the macroscopic fat above — behaves like a benign adenoma; for the ones that aren't fatty enough to call on density alone, a contrast washout protocol helps separate adenomas from the worrisome stuff.
- Liver lesions → LI-RADS (in the right patient). Focal liver lesions in someone at risk for hepatocellular carcinoma get a LI-RADS category; in a low-risk patient, a tiny lesion is far more likely to be a benign cyst or hemangioma.
- Thyroid nodules → TI-RADS. Incidental thyroid nodules are scored on ultrasound features (composition, echogenicity, shape, margins, calcifications) to decide who even needs a biopsy.
The frameworks differ in details but agree on philosophy: stratify by risk, reserve invasive workup for the lesions that earn it, and follow rather than panic.
I won't list exact millimeter cutoffs here, and you shouldn't memorize them cold either — they get revised, and a confidently-recalled-but-outdated number is worse than no number. Know which framework governs which organ, know the axes it scores on, and look up the precise threshold when you're actually staring at the case.
The traps that catch people
The most common framework failure isn't picking the wrong category — it's not finishing the loop. A nodule flagged for "CT in 6 months" with no system to make that scan happen is a finding that quietly evaporates. The recommendation is only as good as the follow-up that completes it.
A second trap: applying a framework to the wrong patient. Screening rules and incidental rules are not interchangeable, and a classification built for cancer patients (where the prior probability is high) will over-call lesions in the worried-well. Always check that the recipe matches the kitchen.
The one thing to carry out the door
An incidentaloma isn't a diagnosis — it's a question. Your job is to route that question into the right published framework, score it on the few features that matter, and hand back a clear next step: leave it, watch it, or work it up. Do that, and you've turned a stressful surprise into a routine, defensible decision. For the broader practice of triaging these findings across organs, the companion page on managing incidental findings is the natural next read.